Advanced search

Dr. Stelios Papadopoulos is Chairman at Cyprus Forest Industries Public Ltd.
Dr. Papadopoulos was previously employed as Chairman by Cyprus Milk Industry Organization, a Director-Finance & Administration by The Housing Finance Corp.
Ltd., and President by Hellenic Students Association.
He also served on the board at International Dairy Federation.
He received his undergraduate degree from the Athens University of Economics & Business, a graduate degree from Lancaster University, and a doctorate degree from Lancaster University.

Stelios Papadopoulos has current job(s) as a member of the supervisory board at Bluetector AG.

Stelios B.
Papadopoulos served as the President of Fisher Scientific International, Inc. from 1988 to 1992.
He was also the Chief Executive Officer of CN Biosciences, Inc. from 1993 to 2001 and the Director of Ngen, Inc. from 1999 to 2009.
Additionally, he served as a Director at US Pathology Labs, Inc. Mr. Papadopoulos obtained his undergraduate degree from Northrop University.

Dr. Stelios Papadopoulos is a Chairman at Eucrates Biomedical Acquisition Corp., a Chairman at Regulus Therapeutics, Inc., a Chairman at Biogen, Inc., a Chairman-Supervisory Board at Biogen GmbH, a Chairman & Treasurer at Fondation Santé, a Chairman at Exelixis, Inc. and an Adjunct Associate Professor at New York University. He is on the Board of Directors at Biogen Idec, Inc. (North Carolina), Diacrin, Inc. (Delaware), National Marrow Donor Program and The BioExec Institute, Inc. Dr. Papadopoulos was previously employed as an Independent Director by BG Medicine, Inc., a Founder by Cellzome Ltd., a Vice Chairman by Cowen & Co. LLC, a Chairman by Anadys Pharmaceuticals, Inc., a President by Instrumentation Laboratory Co., a Chairman by PaineWebber Development Corp., an Investment Banker by PaineWebber, Inc., a Chairman by Cellzome, Inc., and a Vice President-Equity Research Department by Drexel Burnham Lambert, Inc. He also served on the board at GenVec, Inc., SGX Pharmaceuticals, Inc., Biogen Idec New Ventures, Inc., Joule Unlimited Technologies, Inc. and Neuronyx, Inc. He received his graduate degree from New York University, an MBA from New York University and a doctorate degree from New York University.

Stelios Constantinou has a current job as the Head of Investor Relations at Hellenic Exchanges-Athens Stock Exchange SA.